Toolbox

The partner notification service is part of a public health initiative to help protect the public and limit the spread of STIs.

When you choose to use this service to inform one or more sexual partners that you’ve been diagnosed with an STI, you are acting privately and anonymously, as well as individually and of your own volition, in a spirit of goodwill and respect, and with full knowledge of the potential consequences.

Your aim is to inform each person you contact of your diagnosis, in order to encourage them to see a doctor. Once you’ve sent a message, it cannot be changed. Please read the Legal Note before using this service.

 

Choose a card

STI's
  • STI's
Chlamydia
  • Chlamydia
Condylomas (HPV)
  • Condylomas (HPV)
Gonorrhea
  • Gonorrhea
Hepatitis
  • Hepatitis
Herpes
  • Herpes
Syphilis
  • Syphilis
HIV
  • HIV

Email


Welcome

Sexual health and LGBT population

Molluscum contagiosum

Living with HIV

Post-exposure prophylaxis (PEP)

Reminder of vaccination (3rd dose)

To ensure the effectiveness of vaccination against hepatitis A and B (Twinrix), three (3) doses are required :

1re


2e :

1 month after the first dose

3e :

6 months after the first dose

This tool lets you send a friendly reminder for your third dose of vaccine.

Please enter the date of the second dose as well as your email address. You will be notified within five (5) months.

Date of the second vaccine:

:


 

Affiliée à
CHUM
toptéléphone
How does HIV/AIDS infection interact with hepatitis B and hepatitis C?

It is important to note the chronic viral hepatitis evolves more rapidly towards cirrhosis in patients who are also infected (co-infected) with HIV/AIDS. In these situations, a more aggressive treatment approach is recommended and warranted. Hepatitis B (HBV) or C (HCV or Hep C) infection can also have a negative impact on an HIV/AIDS infection as the inflammation caused by the virus may impair the body’s ability to manage and eliminated powerful anti-HIV medications (anti-retrovirals or ART) from the organism. The liver metabolizes a great number of ARTs. Subsequently a chronic hepatitis B or C infection may complicate HIV/AIDS therapy, may limit potential therapeutic choices and may increase possible side effects by cumulative actions on the liver.